aTyr Pharma shorted by Shkreli
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
aTyr Pharma Inc (471A)
aTyr Pharma Inc stock price live, this page displays NASDAQ ATYR stock exchange data. View the ATYR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the aTyr Pharma Inc real time stock price chart below.
What Is the aTyr Pharma Inc Stock Price Today?
The aTyr Pharma Inc stock price today is 4.220.
What Is the Stock Symbol for aTyr Pharma Inc?
The stock symbol for aTyr Pharma Inc is ""ATYR.""
What Stock Exchange Does aTyr Pharma Inc Trade On?
aTyr Pharma Inc is listed and trades on the NASDAQ stock exchange.
Is aTyr Pharma Inc a Good Stock to Buy?
Determining whether aTyr Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ATYR quote. (ISIN: US0021202025)
What Is the aTyr Pharma Inc Stock Price Today?
The aTyr Pharma Inc stock price today is 4.220.
What Is the Stock Symbol for aTyr Pharma Inc?
The stock symbol for aTyr Pharma Inc is ""ATYR.""
What Stock Exchange Does aTyr Pharma Inc Trade On?
aTyr Pharma Inc is listed and trades on the NASDAQ stock exchange.
Is aTyr Pharma Inc a Good Stock to Buy?
Determining whether aTyr Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ATYR quote. (ISIN: US0021202025)
4.220
-0.040(-0.94%)
Delayed Data·
Fair Value
An estimate of a aTyr Pharma Inc's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.220
4.220
52 wk Range
1.470
5.700
471A Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
471A is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a aTyr Pharma Inc's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.2204.220
52 wk Range
1.4705.700
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
471A Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a aTyr Pharma Inc's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings upwards for the upcoming period
- aTyr Pharma to join Russell 2000 and 3000 indexes
- Investing.com
- aTyr Pharma shorted by Shkreli
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
aTyr Pharma Inc Company Profile
aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; and in Phase 1b/2a clinical trial to treat other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase, which is in preclinical development for the treatment fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.
Compare 471A to Peers and Sector
Metrics to compare | 471A | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship471APeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.2x | −1.7x | −0.5x | |
PEG Ratio | −0.55 | 0.00 | 0.00 | |
Price/Book | 6.0x | 2.0x | 2.6x | |
Price / LTM Sales | - | 73.0x | 3.3x | |
Upside (Analyst Target) | - | 285.7% | 42.4% | |
Fair Value Upside | Unlock | 30.2% | 7.2% | Unlock |
Earnings
Latest Release
May 07, 2025
EPS / Forecast
-0.17 / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does aTyr Pharma Inc Trade On?
aTyr Pharma Inc is listed and trades on the Frankfurt Stock Exchange stock exchange.
What Is the Stock Symbol for aTyr Pharma Inc?
The stock symbol for aTyr Pharma Inc is "471A."
What Is the aTyr Pharma Inc Market Cap?
As of today, aTyr Pharma Inc market cap is 386.39M.
What Is aTyr Pharma Inc's Earnings Per Share (TTM)?
The aTyr Pharma Inc EPS (TTM) is -0.80.
From a Technical Analysis Perspective, Is 471A a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has aTyr Pharma Inc Stock Split?
aTyr Pharma Inc has split 1 times.
How Many Employees Does aTyr Pharma Inc Have?
aTyr Pharma Inc has 61 employees.
What is the current trading status of aTyr Pharma Inc (471A)?
As of 31 Jul 2025, aTyr Pharma Inc (471A) is trading at a price of 4.22, with a previous close of 4.26. The stock has fluctuated within a day range of 4.22 to 4.22, while its 52-week range spans from 1.47 to 5.70.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.